Generation Bio Co.
NASDAQ: GBIO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Yalonda Howze
- Employees
- 115
- Headquarters
- Cambridge, United States
- IPO year
- 2020
- Market cap
- $36.0M
- Website
- https://generationbio.com
Loading GBIO…
Loading profile data…Frequently asked questions about GBIO
What does Generation Bio Co. (GBIO) do?
Generation Bio Co. is a biotechnology firm focused on genetic therapies, working to devise treatments for both uncommon and widespread diseases. The company's current development pipeline includes multiple projects, with a particular emphasis on addressing rare and prevalent conditions affecting the liver and retina. Additionally, it directs its...
Where does GBIO trade?
Generation Bio Co. (GBIO) trades on the NASDAQ Global Select.
What sector is GBIO in?
Generation Bio Co. (GBIO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Generation Bio Co.?
Yalonda Howze is the chief executive officer of Generation Bio Co. (GBIO).
Where is Generation Bio Co. headquartered?
Generation Bio Co. is headquartered in United States.
Does GBIO pay a dividend?
Generation Bio Co. (GBIO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GBIO go public?
Generation Bio Co. (GBIO) completed its initial public offering in 2020.